AUTOIMMUN KASALLIKLARDA ENDOTELIAL DISFUNKSIYA VA UNING TROMBOGENEZDAGI ROLI
{$ Etel}:
autoimmun kasalliklar, gemostaz, tromboz, antifosfolipid sindrom, lupus antikoagulyanti, D-dimer, antitrombin III.Abstrak
Ushbu maqolada autoimmun kasalliklarda gemostaz tizimining o‘zgarishlari, ularning patogenetik mexanizmlari, immun yallig‘lanish bilan bog‘liqligi va klinik ahamiyati yoritilgan. Tadqiqot natijalari shuni ko‘rsatadiki, autoimmun jarayonlarda koagulyatsion va antikoagulyant tizim o‘rtasidagi muvozanat buzilishi giperkogulyatsiya, tromboz va gemorragik sindromlarga olib keladi. Gemostazdagi bu o‘zgarishlar kasallikning og‘irlik darajasini belgilab, trombotik asoratlar xavfini oshiradi.
##plugins.themes.default.displayStats.downloads##
Bibliografik havolalar
1. Giannakopoulos B., Krilis S.A. The pathogenesis of the antiphospholipid syndrome. N Engl J Med. 2013.
2. Esmon C.T. Role of coagulation inhibitors in inflammation. Thromb Haemost. 2015.
3. Cervera R. et al. Autoimmune diseases and thrombosis. Semin Thromb Hemost. 2018.
4. Shoenfeld Y., Sherer Y. Autoimmunity and coagulation interplay. Clin Rev Allergy Immunol. 2021.
5. Petri M. Systemic lupus erythematosus and antiphospholipid antibodies. Rheum Dis Clin N Am. 2020.
6. Sidelnikov E. et al. Hemostatic disorders in autoimmune pathology. J Immunopathol. 2022.
7. Aringer M. Pathophysiology of lupus coagulopathy. Lupus Sci Med. 2023.
8. Khamidova D., Rasulova N. Hemostatic imbalance in autoimmune rheumatic diseases. Uzbekistan Med J. 2024.
9. Zhernakova A. et al. Immunohemostatic alterations in systemic lupus erythematosus. J Clin Immunol. 2023.
10. Thompson J., et al. Emerging biomarkers in immune-mediated coagulopathies. Front Immunol. 2024.
Yuklamoq
Nashr qilingan
Nashr
Bo'lim
Guvohnoma
" Litsenziyasi "HRTPS://creseekommons.org/licenseommons.org/licens.org/licens.org/licens.org/licens.org/LICS/4.0/"> Litsenziyalarni litsenziyalash "litsenziyalari Axtibatish "(" Attributi ") 4.0 World
.License Terms of our Journal
